Free National NPI Number Registry
Mark Michael Zalupski
Home > Mark Michael Zalupski
NPI Number Detailed Information
Provider Information:
| Name: | Mark Michael Zalupski |
| Gender: | M |
| Provider License Number If Given: | 4301048736 |
NPI Information:
| NPI: | 1528144490 |
| Entity Type (Individual or Organization): |
1-ind |
| Enumeration Date: | 10/31/2006 |
| Last Update Date: | 5/12/2021 |
| Reputation Report: |
Provider Business Mailing Address:
| Address: | 3621 S STATE ST Ann Arbor, MI 48108 |
| Phone Number: | 7346475299 |
| Fax Number: |
Provider Business Practice Location Address:
| Address: | 1500 E MEDICAL CENTER DR Ann Arbor, MI 48109 |
| Phone Number: | 7349364000 |
| Fax Number: |
Provider Taxonomy:
| Primary: | 207RX0202X |
| Secondary (if any): | |
| State: | MI |
Top Doctors in MI
About Mark Michael Zalupski
Mark Michael Zalupski ( MARK MICHAEL ZALUPSKI ) is An Internal Medicine Physician in Ann Arbor, MI.
The NPI Number for Mark Michael Zalupski is 1528144490.
The current location address for Mark Michael Zalupski is 1500 E MEDICAL CENTER DR Ann Arbor, MI 48109 and the contact number is 7346475299 and fax number is .
The mailing address for Mark Michael Zalupski is 3621 S STATE ST Ann Arbor, MI 48108- 7349364000 (mailing address contact number - 7346475299).
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
Provider Business Location on Map
FAQs:
What is the NPI Number for Mark Michael Zalupski ?
Answer: The NPI Number for Mark Michael Zalupski is 1528144490
Where is Mark Michael Zalupski located?
Answer: Mark Michael Zalupski is located at 1500 E MEDICAL CENTER DR Ann Arbor, MI 48109.
What is the specialty for Mark Michael Zalupski ?
Answer: The Specialty of Mark Michael Zalupski is An Internal Medicine Physician.
Are there any online reviews for Mark Michael Zalupski ?
Answer: Yes! Check It Now.
Are there any other health care providers in Ann Arbor, MI?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Mark Michael Zalupski
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
| Provider Specialty Type | Medical Oncology |
| Source of Provider Specialty | |
| Number of Medicare Part D Claims, Including Refills | 805 |
| Number of Standardized 30-Day Fills | 1183.3666667 |
| Aggregate Cost Paid for All Claims | 400724.87 |
| Number of Day's Supply for All Claims | 30496 |
| Number of Medicare Beneficiaries | 132 |
| Number of Claims, Including Refills, for Beneficiaries Age 65+ | 702 |
| Including Refills, for Beneficiaries Age 65+ | 1049.7 |
| Beneficiaries Age 65+ | 308399.64 |
| Number of Day's Supply for All Claims for Beneficaries Age 65+ | 26997 |
| Number of Medicare Beneficiaries Age 65+ | 118 |
| Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | # |
| Total Claims of Brand-Name Drugs | |
| Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
| Total Claims of Generic Drugs, Including Refills | 600 |
| Aggregate Cost Paid for Generic Drugs | 24541.75 |
| Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | * |
| Total Claims of Other Drugs, Including Refills | |
| Aggregate Cost Paid for Other Drugs | |
| Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by MAPD Plans | 244 |
| Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | 111982.34 |
| Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Standalone PDP Plans | 561 |
| Aggregate Cost Paid for Claims Filled by | 288742.53 |
| Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Low-Income Subsidy | 107 |
| Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | 41687.67 |
| Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | |
| Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | 698 |
| by Low-Income Subsidy | 359037.2 |
| Total Claims of Opioid Drugs, Including | 117 |
| Aggregate Cost Paid for Opioid Drugs | 7969.58 |
| Opioid Claims | 38 |
| Opioid_Tot_Clms divided by the Tot_Clms | 14.534161491 |
| Total Claims of Long-Acting Opioid Drugs | 36 |
| Aggregate Cost Paid for Long-Acting Opioid | 6657.85 |
| Number of Day's Supply of All Long-Acting | 1047 |
| Long-Acting Opioid Claims | 15 |
| Opioid_LA_Tot_Clms divided by the | 30.769230769 |
| Total Claims of Antibiotic Drugs, Including | |
| Aggregate Cost Paid for Antibiotic Drugs | |
| Antibiotic Claims | |
| Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | |
| Including Refills, for Beneficiaries Age 65+ | 23 |
| Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | 889.44 |
| Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
| Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | 14 |
| Average Age of Beneficiaries | 71.515151515 |
| Number of Beneficiaries Age Less Than 65 | |
| Number of Beneficiaries Age 65 to 74 | 68 |
| Number of Beneficiaries Age 75 to 84 | 42 |
| Number of Female Beneficiaries | 73 |
| Number of Male Beneficiaries | 59 |
| Number of Non-Hispanic White | 115 |
| Number of Black or African American | |
| Number of Asian Pacific Islander | |
| Number of Hispanic Beneficiaries | |
| Number of American Indian/Alaskan NativeBeneficiaries | |
| Number of Beneficiaries with Race Not | |
| Only Entitlement | 117 |
| Average Hierarchical Condition Category | 2.2966996768 |
More Providers in ann-arbor , mi
mark Michael zalupski in Other Directories
Provider don't have other directory link yet.
